REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dpb Antibiotics Private Limited (India)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dpb Antibiotics Private Limited Profile Updated: October 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dpb Antibiotics Private Limited is an unlisted company, incorporated on 27/03/2010. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U51397MH2010PTC201353 and registration number is 201353. The company is company, it is engaged in .

Headquarters
509 5Th Flr Exim Link Opp Indira Container Yard Link Road Nahur Bhandup West Mumbai In-Mh In 400078
Mumbai; Maharashtra; Postal Code: 400078

Contact Details: Purchase the Dpb Antibiotics Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Dpb Antibiotics Private Limited report to view the information.
Registered Capital:
Purchase the Dpb Antibiotics Private Limited report to view the information.
Incorporation Date:
March 27, 2010
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
50%
Subsidiaries
Vardhman Chemtech Limited
99.4%
Company Performance
Financial values in the chart are available after Dpb Antibiotics Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
1.76%▲
Total operating revenue
1.95%▲
Operating profit (EBIT)
-96.32%▼
EBITDA
-75.64%▼
Net Profit (Loss) for the Period
-96.77%▼
Total assets
-1.47%▼
Total equity
1.46%▲
Operating Profit Margin (ROS)
-11.62%▼
Net Profit Margin
-12.14%▼
Return on Equity (ROE)
-43.71%▼
Debt to Equity Ratio
29.8%▲
Quick Ratio
0.22%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo